Role of cytokines in immune response to pulmonary tuberculosis

Asian Pacific Journal of Allergy and Immunology

Volumn 19, Issue 3, 2001, Pages 213-219

  Sharma, Sadhna ^a   Bose, Mridula ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 2; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFICACY; DRUG POTENCY; FEVER; GRANULOMA; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFECTION CONTROL; LUNG TUBERCULOSIS; MACROPHAGE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOMES RESEARCH; REVIEW; SYSTEMIC DISEASE; T LYMPHOCYTE; TISSUE INJURY; TISSUE NECROSIS; VACCINATION; WASTING SYNDROME;

BCG VACCINE; CYTOKINES; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKINS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035687859     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Immunopathology of tuberculosis: Role of macrophages and monocytes
2. The immune response in human tuberculosis- implications for tuberculosis control
3. Examining a paradox in the pathogenesis of human pulmonary tuberculosis: Immune activation and suppression/anergy
4. Augmentation of selective monocyte functions in tuberculosis
5. Suppressor adherent cells in human tuberculosis
6. Tuberculosis vaccines: How close to human testing?
7. The interplay between cytokines and T cells in intracellular bacteria
8. Functional diversity of T lymphocytes due to secretion of different cytokine patterns
9. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30 kDa antigen of M. tuberculosis
10. Purified protein derivative of M. tuberculosis and excretory-secretory amigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production
11. Selection of a human T helper type 1-like T cell subset of mycobacteria
12. +) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin
13. Cytokine production at the site of disease in human tuberculosis
14. The pathogenesis of tuberculosis
15. Disruption of cellular inflammatory response to Listeria monocytogenes infection in mice with disruption in targeted genes
16. Disseminated tuberculosis in interferon gamma gene disrupted mice
17. Local production of tumor necrosis factor and interferon-γ in tuberculosis pleuritis
18. Cytokine production in tuberculosis
19. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure
20. Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components
21. Induction of interleukin-1 and tumor necrosis factor by mycobacterial proteins: The monocyte Western blot
22. Interleukin-1 and pathogenesis of the acute-phase response
23. Increased release of IL-β, IL-6 and TNF-α by broncho-alveolar lavage cells lavaged from involved sites in pulmonary tuberculosis
24. Selective induction of transforming growth factor-β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis
25. Interleukin-1: Biology, pathophysiology, and clinical prospects
26. Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis
27. Interleukin-12 at the site of disease in tuberculosis
28. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: Role of phagocytes
29. Increased numbers of IL-12 producing cells in human tuberculosis
30. Interleukin-12 a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity
31. The role of interleukin-12 in acquired immunity to M. tuberculosis infection
32. Interleukin-12 secretion by M. tuberculosis infected macrophages
33. Response of human natural killer cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF
34. Regulation of human cytolytic lymphocyte responses by interleukin-12
35. IL-12 augments antigen-dependent proliferation of activated T lymphocytes
36. IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes. Multiple lymphokines required for proliferation and cytotoxicity
37. IL-2 and IL-12 act in synergy to overcome antigen specific T cell unresponsiveness in mycobacterial disease
38. IL-18/IGIF and mycobacterial infections in humans
39. Production of interleukin-18 in human tuberculosis
40. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis
41. Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens
42. Lipoarabinomannan from M. tuberculosis induces the production of tumour necrosis factor from human and murine macrophages
43. Identification by two-dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of M. tuberculosis
44. Activation of tuberculostatic macrophage functions by γ-interferon, interleukin-4, and tumor necrosis factor
45. Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis
46. T-cell cytokine responses in human infection with M. tuberculosis
47. Cachectin: More than a tumor necrosis factor
48. Biological and clinical aspects of interleukin 6
49. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human macrophages
50. Interleukin-8 and MCAF: Novel leukocyte recruitment and activating cytokines
51. Interleukin-8 as a mediator of angiogenesis
52. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection
53. Properties and functions of interleukin-10
54. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
55. Interleukin-10 down-regulate M. tuberculosis induced Th1 responses and CTLA-4 expression
56. Transforming growth factor-β: The good, the bad and the ugly
57. Transforming growth factor-β modulates the expression of class II histocompatibility antigens on human cells
58. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculosis granulomatous lung lesions
59. Production of transforming growth factor-β by M. avium infected human macrophages is associated with unresponsiveness of IFN-gamma
60. Cytokine/chemokine cascade in immunity to tuberculosis
61. Proinflammatory cytokines can significantly induce human mononuclear phagocytes to produce nitric oxide by a cell maturation-dependent process
62. Nitric oxide dependent killing of Mycobacterium tuberculosis by human mononuclear phagocytes from patients with active tuberculosis
63. Mycobacterium tuberculosis inhibits IFN-γ transcriptional responses without inhibiting activation of STAT-I
64. Clinical and immune responses of tuberculosis patients treated with low dose IL-2 and multidrug therapy
65. The promise of immunotherapy for tuberculosis
66. 2 production and anti-leishmanial capacity of human cultured monocytes mediated by IFN-γ
67. Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony stimulating factor, and interleukin-3 for anti-leishmanial activity and oxidative burst capacity
68. IL-4 inhibits IL-2 receptor expression and IL-2 dependent proliferation of human T cells
69. Molecular regulation of human interleukin-2 and T-cell function by interleukin-4
70. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis
71. Tumor necrosis factor, other cytokines and disease
72. Identification of nitric oxide synthase as a protective locus against tuberculosis